Novo Holdings A/S - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$4,989,000
-81.5%
1,987,5060.0%0.25%
-85.8%
Q2 2020$26,990,000
+4.9%
1,987,506
-41.4%
1.74%
+1.5%
Q1 2020$25,719,000
+31.3%
3,393,039
+9.5%
1.72%
+36.0%
Q4 2019$19,592,000
+61.2%
3,100,0000.0%1.26%
-39.4%
Q3 2019$12,152,000
-19.0%
3,100,0000.0%2.08%
-1.0%
Q2 2019$15,004,000
-40.9%
3,100,0000.0%2.10%
-44.0%
Q1 2019$25,389,000
+48.1%
3,100,0000.0%3.76%
+55.7%
Q4 2018$17,143,000
-37.4%
3,100,0000.0%2.41%
+11.0%
Q3 2018$27,373,000
-11.5%
3,100,0000.0%2.17%
-30.2%
Q2 2018$30,938,000
+4.7%
3,100,0000.0%3.11%
-16.0%
Q1 2018$29,543,000
-10.7%
3,100,000
+39.3%
3.70%
-20.1%
Q4 2017$33,086,000
-10.9%
2,225,000
+17.9%
4.64%
-4.0%
Q3 2017$37,128,000
+42.4%
1,887,535
+4.0%
4.83%
+54.9%
Q2 2017$26,071,000
+122.7%
1,814,289
+42.6%
3.12%
+150.3%
Q1 2017$11,705,000
-20.1%
1,272,247
-16.1%
1.25%
-17.6%
Q3 2015$14,648,000
-6.1%
1,516,3870.0%1.51%
+34.8%
Q2 2015$15,604,000
-7.4%
1,516,3870.0%1.12%
-21.7%
Q1 2015$16,847,000
-4.6%
1,516,3870.0%1.43%
+0.4%
Q4 2014$17,651,000
-47.4%
1,516,3870.0%1.43%
-56.4%
Q3 2014$33,558,000
-60.2%
1,516,387
-50.0%
3.27%
-22.4%
Q2 2014$84,280,0003,032,7744.22%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,031,283$95,485,0005.72%
GREAT POINT PARTNERS LLC 3,510,073$47,667,0003.81%
Logos Global Management LP 1,200,000$16,296,0003.26%
DAFNA Capital Management LLC 762,666$10,357,0002.99%
Baupost Group 15,000,000$203,700,0002.54%
Nantahala Capital Management 6,101,111$82,853,0002.50%
Abrams Capital Management 5,656,462$76,815,0002.48%
Novo Holdings A/S 1,987,506$26,990,0001.74%
Stanley-Laman Group, Ltd. 316,933$4,304,0001.04%
Integral Health Asset Management, LLC 250,000$3,395,0001.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders